FindTrial
Sign In

Usefulness of sitagliptin for type 2 diabetes pacients

Usefulness of sitagliptin for type 2 diabetes pacients - Usefulness of sitagliptin for type 2 diabetes pacients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000005769
Enrollment
300
Registered
2011-06-13
Start date
2011-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

Sitagliptin

Sponsors

Jikei University School of Medicine, Division of Diabetes, Metabolism and Endocrinology Department of Internal Medicine
Lead Sponsor
NTT Medical Center Tokyo, Showa University, Toshiba General Hospital, Toho University Omori Medical center, TOHO University Ohashi Medical center, Toranomon Hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: type2 diabetes whose HbA1c is 6.5 <= , 20 years-old <=

Exclusion criteria

Exclusion criteria: 1)diabetic ketosis, lethargic sleep 2)infection , past history of abdominal operation, past history of ileus, serious injury 3)pregnancy or suspicious pregnancy, lactation 4)renal failure 5)insulin in use

Design outcomes

Primary

MeasureTime frame
Achievement rate for glycemic control target—

Countries

Japan

Contacts

Public ContactTamotsu Yokota

Jikei University School of Medicine Division of Diabetes, Metabolism and Endocrinology Department of Internal Medicine

03-3433-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026